ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Surgical Oncology

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jso.21538PMID 20461761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of matrix metalloproteinase-2 via RNA interference inhibits pancreatic carcinoma cell invasiveness and adhesion.

  2009cited by this paper
• Neuroendocrine tumors of the pancreas.

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Expression Pattern and Functional Relevance of Epidermal Growth Factor Receptor and Cyclooxygenase-2: Novel Chemotherapeutic Targets in Pancreatic Endocrine Tumors?

  2009cited by this paper
• Moesin-dependent cytoskeleton remodelling is associated with an anaplastic phenotype of pancreatic cancer

  2009cited by this paper
• A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development

  2008cited by this paper
• Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells

  2008cited by this paper
• Cannabinoids in pancreatic cancer: Correlation with survival and pain

  2008cited by this paper
• Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis.

  2008cited by this paper
• Transitions between epithelial and mesenchymal states in development and disease.

  2008cited by this paper
• Activated leukocyte cell adhesion molecule: a new paradox in cancer.

  2008cited by this paper
• Hyaluronidases in cancer biology.

  2008cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Population-Based Study of Islet Cell Carcinoma

  2007cited by this paper
• Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies.

  2007cited by this paper
• Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.

  2007cited by this paper
• Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.

  2007cited by this paper
• Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens.

  2006cited by this paper
• Pancreatic Cancer: From Bench to 5-Year Survival

  2006cited by this paper
• Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion.

  2006cited by this paper
• Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer

  2006cited by this paper
• Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.

  2006cited by this paper
• Involvement of CD166 in the Activation of Human γδT Cells by Tumor Cells Sensitized with Nonpeptide Antigens1

  2006cited by this paper
• Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival

  2005cited by this paper
• Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value

  2005cited by this paper
• Endocrine tumours of the pancreas.

  2005cited by this paper
• Axon fasciculation defects and retinal dysplasias in mice lacking the immunoglobulin superfamily adhesion molecule BEN/ALCAM/SC1.

  2004cited by this paper
• Adenovirus-Mediated Transfer of a Truncated Fibroblast Growth Factor (FGF) Type I Receptor Blocks FGF-2 Signaling in Multiple Pancreatic Cancer Cell Lines

  2004cited by this paper
• ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival

  2004cited by this paper
• Relevance of CD6-Mediated Interactions in T Cell Activation and Proliferation1

  2004cited by this paper
• Frontline: Optimal T cell activation requires the engagement of CD6 and CD166

  2004cited by this paper
• Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator

  2004cited by this paper
• ALCAM/CD166 is up‐regulated in low‐grade prostate cancer and progressively lost in high‐grade lesions

  2003cited by this paper
• Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer

  2003cited by this paper
• Neuroendocrine tumors of the pancreas

  2003cited by this paper
• Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.

  2002cited by this paper
• MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).

  1998cited by this paper

• Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma

  2024cites this paper
• Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.

  2024cites this paper
• Single-cell transcriptome analysis of NEUROG3+ cells during pancreatic endocrine differentiation with small molecules

  2023cites this paper
• Galectin-8 Immunohistochemical Profile in Pancreatic Ductal Adenocarcinoma: Emerging Evidence for Its Prognostic Role

  2023cites this paper
• ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient’s Response to Chemotherapies

  2023cites this paper
• ALCAM: A Novel Surface Marker on EpCAMlow Circulating Tumor Cells

  2022cites this paper
• The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers

  2021cites this paper
• ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.

  2021cites this paper
• Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer, a pivotal link to clinical outcome and vascular embolism.

  2021cites this paper
• EphB2 represents an independent prognostic marker in patients with gastric cancer and promotes tumour cell aggressiveness

  2020cites this paper
• Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival

  2019cites this paper
• Microenvironment Influences Cancer Cell Mechanics from Tumor Growth to Metastasis.

  2018cites this paper
• Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells

  2017cites this paper
• MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM

  2016cites this paper
• Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells

  2016influential citation
• Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?

  2016cites this paper
• A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker

  2016cites this paper
• Lesser-Known Molecules in Ovarian Carcinogenesis

  2015cites this paper
• Clinical implication of CD166 expression in salivary gland tumor

  2015cites this paper
• Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer

  2015cites this paper
• ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer

  2015cites this paper
• CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells

  2014influential citation
• RETRACTED ARTICLE: Uncovering the pathogenesis and identifying novel targets of pancreatic cancer using bioinformatics approach

  2014cites this paper
• ctivated leukocyte cell adhesion molecule ( ALCAM / CD 166 ) xpression in head and neck squamous cell carcinoma ( HNSSC ) ill

  2014cites this paper
• Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).

  2014cites this paper
• BIOLOGICAL MECHANISMS IN OVARIAN CARCINOGENESIS INITIATION AND PROGRESSION

  2013cites this paper
• Alcam Regulates Long‐Term Hematopoietic Stem Cell Engraftment and Self‐Renewal

  2013cites this paper
• “GRIGORE. T. POPA” UNIVERSITY OF MEDICINE AND PHARMACY IAŞI FACULTY OF MEDICINE BIOLOGICAL MECHANISMS IN OVARIAN CARCINOGENESIS INITIATION AND PROGRESSION

  2013cites this paper
• Title: Elevated Alcam Shedding in Colorectal Cancer Correlates with Poor Patient Outcome. Disclosure of Potential Conflicts of Interest Hansen Et Al. Page 2

  2013cites this paper
• Plasma Membrane Proteomics of Tumor Spheres Identify CD166 as a Novel Marker for Cancer Stem-like Cells in Head and Neck Squamous Cell Carcinoma*

  2013cites this paper
• Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

  2013cites this paper
• Activated Leukocyte Cell Adhesion Molecule Is a Marker for Thyroid Carcinoma Aggressiveness and Disease-Free Survival

  2013cites this paper
• Prognostic Value of CD166 Expression in Cancers of the Digestive System: A Systematic Review and Meta-Analysis

  2013cites this paper
• Detection of Activated Leukocyte Cell Adhesion Molecule in the Serum of Breast Cancer Patients and Implications for Prognosis

  2012cites this paper
• A regulatory network for human adenocarcinoma

  2012cites this paper
• Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients

  2012cites this paper
• ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer

  2012influential citation
• ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.

  2011cites this paper
• ALCAM: Basis Sequence: Mouse.

  2011cites this paper
• Looking to the Future: Biomarkers in the Management of Pancreatic Adenocarcinoma

  2011cites this paper
• Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma

  2011cites this paper